留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

加味宣白承气汤治疗重症肺炎合并急性胃肠损伤的临床研究

何金波 毛峥嵘 宋鹏阳

何金波, 毛峥嵘, 宋鹏阳. 加味宣白承气汤治疗重症肺炎合并急性胃肠损伤的临床研究[J]. 南京中医药大学学报, 2022, 38(2): 103-108. doi: 10.14148/j.issn.1672-0482.2022.0103
引用本文: 何金波, 毛峥嵘, 宋鹏阳. 加味宣白承气汤治疗重症肺炎合并急性胃肠损伤的临床研究[J]. 南京中医药大学学报, 2022, 38(2): 103-108. doi: 10.14148/j.issn.1672-0482.2022.0103
HE Jin-bo, MAO Zheng-rong, SONG Peng-yang. Clinical Study on the Treatment of Severe Pneumonia Combined with Acute Gastrointestinal Injury by Supplemented Xuanbai Chengqi Decoction[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(2): 103-108. doi: 10.14148/j.issn.1672-0482.2022.0103
Citation: HE Jin-bo, MAO Zheng-rong, SONG Peng-yang. Clinical Study on the Treatment of Severe Pneumonia Combined with Acute Gastrointestinal Injury by Supplemented Xuanbai Chengqi Decoction[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(2): 103-108. doi: 10.14148/j.issn.1672-0482.2022.0103

加味宣白承气汤治疗重症肺炎合并急性胃肠损伤的临床研究

doi: 10.14148/j.issn.1672-0482.2022.0103
基金项目: 

河南省中医药科学研究专项课题 2018ZY1002

详细信息
    作者简介:

    何金波, 男, 主治医师, E-mail: hejinbo2009@126.com

    通讯作者:

    毛峥嵘, 男, 主任医师, 主要从事中西医结合治疗急危重症的研究, E-mail: maozhengrong@126.com

  • 中图分类号: R256.11

Clinical Study on the Treatment of Severe Pneumonia Combined with Acute Gastrointestinal Injury by Supplemented Xuanbai Chengqi Decoction

  • 摘要:   目的  评价加味宣白承气汤治疗重症肺炎合并急性胃肠损伤(Acute gastrointestinal injury, AGI)的临床疗效。  方法  采用随机对照研究, 将76例重症肺炎合并AGI住院患者随机分成对照组和治疗组各38例, 对照组给予西医常规治疗, 包括积极治疗原发病和合并疾病、尽早给予肠内营养、胃肠动力药等, 治疗组在对照组治疗基础上联用加味宣白承气汤鼻饲给药, 疗程均为7 d。治疗前及治疗7 d评估2组患者临床疗效; 治疗前及治疗3 d、治疗7 d检测胃肠功能指标变化[胃肠功能衰竭(Gastrointestinal failure,GIF)评分、肠内营养日喂养量和腹内压力(Intraabdominal pressure,IAP)],ELISA法检测患者血清胃动素(Motilin,MTL)水平及二胺氧化酶(Diamine oxidase,DAO)活性; 记录患者住院期间机械通气时间、ICU住院时间及28 d病死率。  结果  治疗后, 治疗组总有效率优于对照组(P < 0.05);治疗组GIF、肠内营养日喂养量、IAP显著改善(P < 0.01), 治疗组治疗7 d GIF、肠内营养日喂养量、IAP改善优于对照组(P < 0.05);治疗3 d、治疗7 d 2组患者血清MTL水平、DAO活性均显著升高(P < 0.01), 治疗组治疗3 d、治疗7 d MTL水平显著高于对照组(P < 0.05,P < 0.01);治疗组机械通气时间、ICU住院天数均明显少于对照组(P < 0.01);2组患者28 d病死率比较无显著性差异(P>0.05)。  结论  加味宣白承气汤能有效改善重症肺炎合并AGI患者的胃肠功能, 缩短ICU住院时间, 促进患者康复。

     

  • 表  1  2组患者基线资料比较(x±s, n=38)

    Table  1.   Comparison of general baseline data between the two groups (x±s, n=38)

    组别 年龄/岁 APACHE Ⅱ 合并疾病 AGI分级
    COPD 肺纤维化 脑血管病 冠心病 Ⅰ级 Ⅱ级 Ⅲ级
    治疗组 29 9 70.82±1.60 25.97±0.86 12 7 19 10 7 21 10
    对照组 28 10 71.87±1.98 26.75±0.95 13 6 18 13 8 20 10
    下载: 导出CSV

    表  2  2组患者临床疗效比较(n=38)

    Table  2.   Comparison of clinical efficacy between the two groups (n=38)

    组别 显效 有效 无效 总有效率/%
    治疗组 23 10 5 86.84*
    对照组 13 11 14 63.16
    注: 2组比较, χ2=7.098, *P < 0.05。
    下载: 导出CSV

    表  3  2组患者治疗前后胃肠功能指标变化比较(x±s, n=38)

    Table  3.   Comparison of gastrointestinal function indexes between the two groups before and after treatment (x±s, n=38)

    组别 时间 GIF 肠内营养日喂养量/(mL·d-1) IAP/kPa
    治疗组 治疗前 2.11±0.69 351.97±176.18 1.72±0.48
    治疗3 d 1.63±1.02** 540.92±362.23** 1.22±0.57**
    治疗7 d 0.76±1.24**△△# 980.39±473.46**△△# 0.85±0.57**△△#
    对照组 治疗前 2.08±0.71 350.13±172.52 1.71±0.52
    治疗3 d 2.03±1.05 418.82±325.79 1.49±0.66*
    治疗7 d 1.71±1.66 648.95±601.21**△△ 1.35±0.93*△
    注: 行重复测量方差分析, F(GIF)组间=4.131, P < 0.05;F(GIF)时间=27.516, P < 0.01;F(GIF)交互=8.549, P < 0.01;F(肠内营养日喂养量)组间=4.603, P < 0.05;F(肠内营养日喂养量)时间=55.600, P < 0.01;F(肠内营养日喂养量)交互=6.752, P < 0.01;F(IAP)组间=4.072, P < 0.05;F(IAP)时间=43.074, P < 0.01;F(IAP)交互=7.610, P < 0.01;与治疗前比较, *P < 0.05, * *P < 0.01;与治疗3 d比较, P < 0.05, △△P < 0.01;与对照组比较, #P < 0.05。
    下载: 导出CSV

    表  4  2组患者治疗前后血清MTL、DAO水平比较(x±s, n=38)

    Table  4.   Comparison of serum MTL and DAO between the two groups before and after treatment (x±s, n=38)

    组别 时间 MTL/(ng·L-1) DAO/(U·L-1)
    治疗组 治疗前 220.09±14.39 135.00±23.30
    治疗3 d 271.93±33.47**## 107.10±36.80**
    治疗7 d 328.05±46.36**△△# 58.47±44.20**△△
    对照组 治疗前 219.52±17.47 135.29±22.42
    治疗3 d 247.93±43.20** 114.43±34.40**
    治疗7 d 282.16±77.81**△△ 87.86±59.00**△△
    注: 行重复测量方差分析, F(MTL)组间=8.295, P < 0.01;F(MTL)时间=134.304, P < 0.01;F(MTL)交互=9.471, P < 0.01;F(DAO)组间=2.646, P>0.05;F(DAO)时间=120.505, P < 0.01;F(DAO)交互=7.124, P < 0.01;与治疗前比较, * *P < 0.01;与治疗3 d比较, △△P < 0.01;与对照组比较, #P < 0.05, ##P < 0.01。
    下载: 导出CSV

    表  5  2组患者机械通气时间、ICU住院时间及28 d病死率比较(x±s, n=38)

    Table  5.   Comparison of mechanical ventilation time, ICU stay time and 28-d mortality between the two groups (x±s, n=38)

    组别 机械通气时间/d ICU住院天数/d 28 d病死率/%
    治疗组 10.42±5.23** 13.08±6.70** 23.68
    对照组 15.21±7.60 17.95±8.47 36.84
    注: 2组比较, χ28天病死率2=1.559;**P < 0.01。
    下载: 导出CSV
  • [1] HIRANI NA, MACFARLANE JT. Impact of management guidelines on the outcome of severe community acquired pneumonia[J]. Thorax, 1997, 52(1): 17-21. doi: 10.1136/thx.52.1.17
    [2] REINTAM BLASER A, MALBRAIN MLNG, STARKOPF J, et al. Gastrointestinal function in intensive care patients: Terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems[J]. Intensive Care Med, 2012, 38(3): 384-394. doi: 10.1007/s00134-011-2459-y
    [3] 任珊, 宫蕊, 龙玲, 等. 厚朴排气合剂对肺炎合并急性胃肠功能损伤患者预后的影响研究[J]. 现代中西医结合杂志, 2020, 29(18): 1973-1976. doi: 10.3969/j.issn.1008-8849.2020.18.008

    REN S, GONG R, LONG L, et al. Study on the effect of Houpo Paiqi mixture on the prognosis of patients with pneumonia complicated with acute gastrointestinal injury[J]. Mod J Integr Tradit Chin West Med, 2020, 29(18): 1973-1976. doi: 10.3969/j.issn.1008-8849.2020.18.008
    [4] 高志凌, 金魁, 赵越, 等. 益气通腑方干预老年严重脓毒症患者急性胃肠损伤的临床研究[J]. 时珍国医国药, 2018, 29(4): 902-904. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY201804045.htm

    GAO ZL, JIN K, ZHAO Y, et al. Clinical study of Yiqi Tongfu Prescription on acute gastrointestinal injury in elderly patients with severe sepsis[J]. Lishizhen Med Mater Med Res, 2018, 29(4): 902-904. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY201804045.htm
    [5] 孙芳园, 许开亮, 袁林, 等. 电针结合穴位敷贴治疗脓毒症急性胃肠损伤的临床研究[J]. 中国中医急症, 2020, 29(7): 1165-1167, 1195. doi: 10.3969/j.issn.1004-745X.2020.07.011

    SUN FY, XU KL, YUAN L, et al. Study on electroacupuncture combined with acupoint application on acute gastrointestinal injury due to Sepsis[J]. J Emerg Tradit Chin Med, 2020, 29(7): 1165-1167, 1195. doi: 10.3969/j.issn.1004-745X.2020.07.011
    [6] 于凯江, 管向东, 严静. 中国重症医学专科资质培训教材[M]. 2版. 北京: 人民卫生出版社, 2016: 4-6.

    YU KJ, GUAN XD, YAN J. Training Materials for Specialty Qualification of Critical Care Medicine in China[M]. 2nd edition. Beijing: People's medical publishing house, 2016: 4-6.
    [7] 陈灏珠, 林果为, 王吉耀. 实用内科学[M]. 14版. 北京: 人民卫生出版社, 2013: 1722.

    CHEN HZ, LIN GW, WANG JY. Practice of Internal Medicine[M]. 14th edition. Beijing: People's medical publishing house, 2013: 1722.
    [8] BROWN SM, JONES BE, JEPHSON AR, et al. Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia[J]. Crit Care Med, 2009, 37(12): 3010-3016. doi: 10.1097/CCM.0b013e3181b030d9
    [9] REINTAM A, PARM P, KITUS R, et al. Gastrointestinal failure score in critically ill patients: A prospective observational study[J]. Crit Care, 2008, 12(4): R90. doi: 10.1186/cc6958
    [10] KRON IL, HARMAN PK, NOLAN SP. The measurement of intra-abdominal pressure as a criterion for abdominal re-exploration[J]. Ann Surg, 1984, 199(1): 28-30. doi: 10.1097/00000658-198401000-00005
    [11] BLASER AR, POEZE M, MALBRAIN MLNG, et al. Gastrointestinal symptoms during the first week of intensive care are associated with poor outcome: A prospective multicentre study[J]. Intens Care Med, 2013, 39(5): 899-909. doi: 10.1007/s00134-013-2831-1
    [12] 秦景明. 症因脉治[M]. 北京: 人民卫生出版社, 2006: 287.

    QIN JM. Symptom, Cause, Pulse, and Treatment[M]. Beijing: People's medical publishing house, 2006: 287.
    [13] 吴瑭. 温病条辨[M]. 北京: 人民卫生出版社, 2005: 53.

    WU T. Warm Disease Stripe Discrimination[M]. Beijing: People's medical publishing house, 2005: 53.
    [14] 王欢. 胃肠激素与胃肠道功能及疾病的关系[J]. 医学综述, 2013, 19(15): 2735-2738. doi: 10.3969/j.issn.1006-2084.2013.15.016

    WANG H. The relationship between gastrointestinal hormones and gastrointestinal function and diseases[J]. Med Rev, 2013, 19(15): 2735-2738. doi: 10.3969/j.issn.1006-2084.2013.15.016
    [15] SANGER GJ. Motilin receptor neuropharmacology: Revised understanding[J]. Curr Opin Pharmacol, 2012, 12(6): 641-646. doi: 10.1016/j.coph.2012.07.012
    [16] MENG Y, ZHANG Y, LIU M, et al. Evaluating intestinal permeability by measuring plasma endotoxin and diamine oxidase in children with acute lymphoblastic leukemia treated with high-dose methotrexate[J]. Anticancer Agents Med Chem, 2016, 16(3): 387-392. doi: 10.2174/1871520615666150812125955
    [17] 焦东海, 沈学敏, 景炳文. 单味大黄治疗急性胰腺炎17年研究[J]. 中医杂志, 1994, 35(3): 172-173. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ199403030.htm

    JIAO DH, SHEN XM, JING BW. Single rhubarb in the treatment of acute pancreatitis for 17 years[J]. J Tradit Chin Med, 1994, 35(3): 172-173. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ199403030.htm
    [18] 陈德昌, 景炳文, 杨兴易, 等. 大黄对肠黏膜屏障保护作用的机制探讨[J]. 中国危重病急救医学, 1996(8): 449-450. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWZB608.000.htm

    CHEN DC, JING BW, YANG XY, et al. The discussion on Mechanism of protective effect of rhubarb on intestinal mucosal barrier[J]. Chin Crit Care Med, 1996(8): 449-450. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWZB608.000.htm
  • 加载中
表(5)
计量
  • 文章访问数:  243
  • HTML全文浏览量:  95
  • PDF下载量:  24
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-09-28
  • 网络出版日期:  2022-03-01
  • 发布日期:  2022-02-10

目录

    /

    返回文章
    返回